Abstract:Abstract Background Elevated lactate dehydrogenase (LD) levels during acute phase of COVID-19 is known to reflect multiple organ injuries and clinical severity. However, clinical implication and origin of elevated LD after convalescence have not been elucidated. Methods We prospectively enrolled non-vaccinated severe COVID-19 patients with an oxygen demand greater than FiO2 0.4 and followed them up to one year after discharge. Laboratory values and modified Medical Research Council (mMRC) dyspnea scale were collected at each outpatient visit. To investigate the potential association between elevated LD levels and CD4+T cell activities, fluorescence-activated cell sorting (FACS) and intracellular cytokine staining (ICS) of INF-γ, TNF-α, IL-4, and IL-17A were conducted. Results A total of 74 patients were included, of which 46 (62%) were male, the median age was 59 years (IQR 52–69), and peak FiO2 during hospitalization was 0.65 (IQR 0.50–0.80). At discharge, median absolute lymphocyte count (ALC) was 1.29 x103/μL (IQR 0.93–1.75), median C-reactive protein (CRP) was 0.23 mg/dL (IQR 0.06–0.52), and median LD was 334 IU/L (IQR 276–450). After discharge, ALC increased (R2 = 0.1434, P < 0.001) and LD decreased (R2 = 0.0838, P < 0.001) overtime, but CRP level did not show time-dependent changes (Figure 1A-C). Increased LD (R2 = 0.160, P < 0.001) and CRP (R2 = 0.028, P = 0.024) levels were significantly associated with higher grade of mMRC scales, while ALC was not associated with mMRC scale (Fig 1D-F). To investigate the potential association between elevated LD level and CD4+T cell activation, serial 38 PBMC specimens from 10 patients were further investigated. CD4+T cells were identified using FACS gating and then stained for intracellular cytokines. The proportion of TNF-α+CD4+T cells (R2 = 0.547, P < 0.001; Fig 2A) and IL-17A+CD4+T cells (R2 = 0.419, P = 0.009; Fig 2B) after spike protein stimulation were positively correlated with LD levels, while the proportion of Treg did not.Figure 1.Time-dependent changes in ALC, CRP and LD levels and their association with the degree of dyspnea (mMRC scale) after discharge.(A) Linear regression with ALC and time. (B) Linear regression with CRP and time. (C) Linear regression with LD and time. (D) Linear regression with ALC and mMRC. (E) Linear regression with CRP and mMRC. (F) Linear regression with LD and mMRC. *Statistically significant. ALC, absolute lymphocyte count; CRP, C-reactive protein; LD, lactate dehydrogenase; WBC, white blood cell, mMRC, modified Medical Research Council.Figure 2.FACS gating for CD4+T cells and ICS correlation with serum LD levels after convalescence.FACS gating for CD3+CD4+T cells and ICS for TNF-α (A) and IL-17A (B) were conducted. Serum LD levels after convalescence showed significant correlations with the proportion of TNF-α+CD4+T cells (A) and that of IL-17A+CD4+T cells (B). FACS, fluorescence-activated cell sorting; ICS, intracellular cytokine staining; LD, lactate dehydrogenase. Conclusion Elevated LD in convalescent severe COVID-19 patients reflects delayed clinical recovery and activated Th1 and Th17 responses Disclosures All Authors: No reported disclosures

449. Elevated Lactate Dehydrogenase in Convalescent Severe COVID-19 Patients Reflects Delayed Clinical Recovery and Activated Th1 and Th17 Responses

Longitudinal Clinical and Radiographic Evaluation Reveals Interleukin-6 As an Indicator of Persistent Pulmonary Injury in COVID-19

Proteomic and Metabolomic Investigation of Serum Lactate Dehydrogenase Elevation in COVID‐19 Patients

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Lactate Dehydrogenase and Susceptibility to Deterioration of Mild COVID-19 Patients: a Multicenter Nested Case-Control Study

Persistent CD19+ B Cell Lymphopenia in Critically Ill COVID-19 Patients 50 Days after Symptom Onset

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals

Implications of LDH in patients with coronavirus disease 2019 pneumonia

LDH and NLR, as inflammatory markers, the independent risk factors for COVID-19 complicated with respiratory failure in elderly patients

Distinct airway immune cell constitution in persistent post COVID-19 ILD.

Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients

Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase

Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Serum Lactate Dehydrogenase Level as a Prognostic Factor for COVID-19: A Retrospective Study Based on a Large Sample Size

CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil‐to‐lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection

Dynamics of peripheral immune cells and their HLA‐G and receptor expressions in a patient suffering from critical COVID‐19 pneumonia to convalescence

Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study

Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients

Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19

Dynamic lymphocyte-CRP ratio as a predictor: a single-centre retrospective study on disease severity and progression in adult COVID-19 patients